×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
How Risk-Based Monitoring and eSource Methodologies Are Impacting Clinical Sites, Patients, Regulators and Sponsors
Session Chair(s)
Jules Mitchel, PhD, MBA
President and CEO
THI Pharma Services, United States
This symposium will show how risk-based monitoring and eSource methodologies are impacting the way clinical trials are being conducted and managed.
Learning Objective : Discuss results and experience from completed and ongoing clinical trials; Identify how eSource and risk-based monitoring methodologies are impacting the clinical research enterprise including clinical research sites, patients, regulators, quality assurance, clinical research associates (CRA), and project, safety and data managers.
Speaker(s)
The Time Is Now for Risk-Based Monitoring: Frances Nolan, MBA
Independent Consultant
Independent Consulting, United States
Overcoming Clinical Trial Data Collection Challenges with eSource Solution and Leveraging Mobile Technologies: Avik Pal, MBA
Chief Executive Officer
CliniOps, United States
Innovation by Design: Using eSource to Maximize Clinical Development Productivity and Efficiency : Edward Stephen Seguine, MBA
Chief Executive Officer
Elemental Machines, United States
Have an account?
Ways to register
Registration override should work.